Abstract-Anderson's disease is a rare, hereditary hypocholesterolemic syndrome characterized by chronic diarrhea, steatorrhea, and failure to thrive associated with the absence of apo B48 -containing lipoproteins. To further define the molecular basis of the disease, we studied 8 affected subjects in 7 unrelated families of North African origin after treatment with a low-fat diet. Lipid loading of intestinal biopsies persisted, but the pattern and extent of loading was variable among the patients. Electron microscopy showed lipoprotein-like particles in membrane-bound compartments, the densities (0.65 to 7.5 particles/ 2 ) and the mean diameters (169 to 580 nm) of which were, in general, significantly larger than in a normal fed subject (0.66 particles/ 2 , 209 nm mean diameter). There were also large lipid particles having diameters up to 7043 nm (average diameters from 368 to 2127 nm) that were not surrounded by a membrane. Rarely, lipoprotein-like particles 50 to 150 nm in diameter were observed in the intercellular spaces. Intestinal organ culture showed that apo B and apo AIV were synthesized with apparently normal molecular weights and that small amounts were secreted in lipid-bound forms (density Ͻ1.006 g/mL). Normal microsomal triglyceride transfer protein (MTP) and activity were also detected in intestinal biopsies. Segregation analyses of 4 families excluded, as a cause of the disease, significant regions of the genome surrounding the genes for apo AI, AIV, B, CI, CII, CIII, and E, as were the genes encoding 3 proteins involved in intracellular lipid transport, MTP, and fatty acid binding proteins 1 and 2. The results suggest that a factor other than apoproteins and MTP are important for human intestinal chylomicron assembly and secretion.
T
here are 3 inherited lipoprotein deficiency states, characterized by hypocholesterolemia, which affect apo B-containing lipoproteins: abetalipoproteinemia, familial hypobetalipoproteinemia, and Anderson's disease or chylomicron retention disease. 1 Abetalipoproteinemia is a rare disease. This autosomal recessive disorder manifests itself in infancy, and although the clinical expression is variable, it is characterized by profound hypocholesterolemia, hypotriglyceridemia, lipid malabsorption, diarrhea, retinitis pigmentosa, acanthocytosis, spinocerebellar degeneration, and the complete absence of apo B-containing lipoproteins. A defect in lipoprotein assembly is due to mutations in the gene encoding the large subunit of the microsomal triglyceride transfer protein (MTP) (see reference 2 for a review).
Familial hypobetalipoproteinemia has an autosomal codominant form of transmission. Subjects who are homozygous for "null-alleles," in which plasma apo B is absent, are phenotypically similar to subjects having abetalipoproteinemia (see reference 3 for a review). Subjects who are homozygous but in which truncated forms of apo B are found in the plasma are, in general, asymptomatic clinically, as are subjects who are heterozygous for the disease. However, in both cases there are decreased plasma and LDL cholesterol levels. The disease arises from mutations in the apo B gene. Based on the levels of plasma apo B, the frequency of the heterozygous form of familial hypobetalipoproteinemia has been estimated to be 1/500 to 1/1000 in Western populations. 3 Anderson's disease and chylomicron retention disease are the terms used to describe subjects having hypobetalipoproteinemia with selective absence of apo B48. 1 Thirty-five cases 4 -21 have been reported, including the following 2 series: one from France consisting of 10 cases 12 under the name of Anderson's disease and one from Canada consisting of 8 cases 14, 15 under the name of chylomicron retention disease. Subjects with these disorders exhibit the clinical manifesta-tions initially described by Anderson and colleagues 4 that consist of a malabsorption syndrome with steatorrhea and growth retardation. Endoscopy shows a white stippling-like hoar frosting covering the mucosal surface of the small intestine. Neurological signs, although variable, consist most frequently of a loss of reflexes. Biochemically, there is an absence of apo B48 -containing lipoproteins and no postprandial chylomicrons are detected, whereas lipoproteins containing apo B100 are present, although in decreased amounts. There are low plasma levels of HDL as well as low levels of total lipids, cholesterol, phospholipids, carotenoids, and lipid soluble vitamins. There are, however, normal fasting triglyceride levels. There is little acanthocytosis and no retinitis pigmentosa. Both absorption of luminal fatty acids and their consecutive esterification by the epithelial cells appear normal. On institution of a low-fat diet supplemented with lipid soluble vitamins (A and E) and essential fatty acids, normal growth resumes with abatement of the gastrointestinal symptomatology. Departure from the low-fat diet results in rapid relapse and recurrence of symptoms.
Immunoenzymatic 12, 14 and organ culture studies 15 have shown the presence of apo B48 in enterocytes, which suggests that mutations in the apo B gene are not the cause of the disease. Further, genetic linkage studies have excluded the apo B gene in 8 cases of Anderson's disease in 3 families [17] [18] and in 2 cases (1 family) of chylomicron retention disease. 19 The apo B messenger RNA appeared to be correctly edited in 2 cases of chylomicron retention disease in 1 family, 19 suggesting that a defect in intestinal apo B editing is not involved. Intestinal ultrastructural studies have shown that villi are present in normal number and length but that the enterocytes are overloaded with fat droplets. In contrast to abetalipoproteinemia, the presence of chylomicron and VLDL-sized particles has been noted in membrane-bound compartments in the enterocytes of some patients, 7, 8, 14, 18, 20, 21 suggesting that lipoprotein assembly may take place. Roy and colleagues 14 proposed the name chylomicron retention disease for the disorder in their patients. The molecular basis of Anderson's disease (chylomicron retention disease) has not been established.
The purpose of this study was to investigate the roles of the major apolipoproteins and 3 intracellular lipid transport proteins in the pathogenesis of Anderson's disease. We performed an ultrastructural study of the enterocytes to assess the nature of the lipid accumulations in the cells of our patients as compared with those in other patients with Anderson's disease and chylomicron retention disease. We further used intestinal organ culture to evaluate the biosynthesis and secretion of major apolipoproteins and MTP. Finally, we looked for evidence of genetic linkage between apolipoprotein and intracellular lipid transport genes and Anderson's disease using highly polymorphic genetic markers.
Methods

Pedigrees
The protocols used in these studies were approved by the Institut National de la Santé et de la Recherche Médicale as part of a Biomedical Project (RBM 93018) and by a bioethics committee, Comité Consultatif de Protection des Personnes dans la Recherche Biomédicale de Paris-Hôpital Bichat-C. Bernard, registration No. 94002. Informed, written consent was obtained from all participants or from their legal guardians. The diagnosis of Anderson's disease was made on the basis of the clinical findings (diarrhea, steatorrhea, and malabsorption), endoscopy (presence of a "white hoary" layer or "gelée blanche" on the small intestine mucosa), the intestinal biopsy (vacuolated enterocytes that stain positively with oil red O), the levels of plasma cholesterol (hypocholesterolemia), the presence of apo B100 and the absence of apo B48 in the plasma, and the absence of chylomicrons and apo B48 in the plasma after a fat feeding. The parents of the patients were asymptomatic. The patients with pedigrees 100 (Sa.B. and So.B.), 200 (M.K.), 400 (A.B.), 500 (A.C.), and 600 (Y.Z.); Figure 1 ; and M.B. have been described in the literature. 5, 7, 9, 12, 16, 17 The pertinent clinical and biochemical features of the patients have been summarized in Table 1 . The causes of the deaths of the 3 siblings of M.K. are unknown. Previously unpublished plasma lipid and apolipoprotein values for the father and mother, respectively, of M.K. are cholesterol, 5.77 and 4.42 mmol/l (normalϭ4 to 7); triglyceride, 3.43 and 1.26 mmol/l (normalϭ0.5 to 2); apo B, 151 and 94 mg/dL (normalϭ60 to 100); and apo AI, 135 and 131 mg/dL (normalϭ120 to 160). Because no details concerning the siblings of M.B. are available, other than the fact that an older brother and 2 older sisters may be affected, the pedigree of this patient is not shown.
The propositus of pedigree 300 (O.A.) was born January 29, 1985 , the third of 3 children from Algerian parents. The major symptom was intermittent diarrhea that began at 4 months of age. At 2 years of age, a diagnosis of celiac disease was made and a gluten free diet was begun. She presented to the hospital at age 6 years with growth Figure 1 . Pedigrees of the Anderson's disease families. Square symbols denote males and circular symbols denote females. Filled symbols represent an Anderson's disease patient, partially filled symbols represent obligate heterozygotes, and open symbols represent normal or heterozygous siblings because no diagnostic feature allows a distinction to be made as to the genotype in their case. A slanted bar indicates that the subject is deceased. Pertinent clinical and biochemical data concerning the patients are summarized in Table 1 .
retardation (Ϫ4 SD in weight and Ϫ0.5 SD in height), steatorrhea, diarrhea, and abdominal swelling. The deep tendon reflexes were normal. Osteoporosis was present and the bone age was estimated, radiographically, to be 3 years. Hematological analysis showed an anemia without the presence of acanthocytosis. Plasma lipid values (mmol/l) were triglycerides 0.65; cholesterol, 2.25; and phospholipid, 1.25 (Nϭ1.8 to 3.2). Plasma apoprotein values (mg/dL) were apo AI, 50; apo AII, 55 (normalϭ40 to 60); and apo B, 62. The vitamin A level was 1.43 mol/l (Nϭ1.1 to 2.9) and the vitamin E level was 4 mol/l (Nϭ14 to 32). Endoscopy showed a "white hoary frosting" (gelée blanche) and the intestinal biopsy showed fat loaded enterocytes in an otherwise normal mucosa. Plasma cholesterol levels of the father and the mother were 4.1 and 4.4 mmol/l, respectively. The diagnosis of Anderson's disease was made on the criteria outlined above after elimination of other possible causes of malabsorption. After installation of a low-fat diet and vitamin A and E supplementation, digestive symptoms abated.
Intestinal Biopsy Specimens
Intestinal biopsy specimens (ϳ5 to 10 mg each) were obtained between 8 and 10 AM during upper gastrointestinal endoscopy for follow-up from patients with Anderson's disease who had fasted for 12 to 15 hours. Biopsies were obtained with a pediatric endoscopic capsule in the second or third part of the duodenum. The patients had been treated with a low-fat diet supplemented with vitamins A and E for at least 6 months leading up to the endoscopic procedure. Intestinal biopsy specimens were obtained from 11 fasted normal subjects who had been following their normal diet and who were undergoing endoscopy for unrelated causes. An intestinal biopsy was also obtained from one normal subject 1.5 hours after 50 mL olive oil was instilled into the stomach. The preparation of ultrathin sections of biopsies for electron microscopy and western blots for MTP protein and the assay for MTP activity were performed as previously described (references 22 and 23, respectively). The 99% confidence intervals for normal MTP activity were calculated using the SigmaStat statistical analysis software (Jandel Scientific) from the measurements of MTP activity in 5 normal subjects. The particle densities and mean particle diameters in biopsies were measured on photographic enlargements (6000 to 96 000) of electron micrographs and statistical analysis was performed with the SigmaStat software. Particle density measurements were made in several different regions of the biopsy and included several hundred particles. Between 115 and 561 particles were measured for the calculation of the particle diameters for each patient. Organ culture of intestinal fragments and metabolic labeling protocols were begun Ͻ30 minutes after biopsy. 22,24 -25 The incorporation of labeled methionine into the cellular proteins was evaluated by precipitating an aliquot with trichloroacetic acid (TCA) followed by scintillation counting. Immunoprecipitation of biopsy homogenates or culture media was performed with polyclonal antibodies directed against the protein of interest. Rabbit polyclonal antibodies to apo B and apo AIV were the gifts of Dr A. Mazur of Institut National de la Recherche Agronomique, Champanelle, France and Dr. L. Lagrost, Institut National de la Santé et de la Recherche Médicale, Dijon, France. Antibodies to MTP were as previously described. 23 Treatment of the immunoprecipitates with endo-␤-N-acetyl glucosaminidase H and endoglycosidase F/peptide-N 4 -(acetyl-␤-glucosaminyl)-asparagine amidase (PNGase F) to assess the extent of glycosylation of apo AIV was performed according to the manufacturer's protocol (Boehringer Mannheim). After immunoprecipitation, samples were analyzed using sodium dodecyl sulfate (SDS) polyacrylamide gels as previously described. 22,24 -26 For the quantitative analysis of apo AIV and apo B, all of the immunoprecipitated material was loaded onto the SDS gel. After autoradiography, densitometry was performed and the values were normalized with respect to the amount of TCA precipitable incorporated material in the biopsies. Chylomicrons in the biopsy or secreted into the biopsy culture medium were isolated by isopycnic centrifugation at density 1.006 g/mL at 40 000 rpm in a 50Ti rotor for 1 hour at 4°C, as previously described. 27 
DNA Isolation and Genotyping
Genomic DNA was extracted from peripheral blood leukocytes from patients and from their families (pedigrees 100, 200, 300, and 400) using standard techniques. 28 Oligonucleotides for genotyping MTP, apo B, apo CII, and apo CIII were as previously described. 29 -32 For these genes and for the other genes (apo AI, apo AIV, apo E, and FABP 1 and 2), highly polymorphic microsatellite-type markers spanning the regions where these genes are located 33, 34 were also used (see Tables 3 to 6 ).
DNA amplification was performed by polymerase chain reaction (PCR) in a Hybaid thermocycler using a standard program of denaturation at 94°C for 10 minutes followed by 30 cycles of amplification consisting of denaturation at 94°C for 30 seconds, annealing at 55°C for 30 seconds, and extension at 72°C for 30 seconds and terminated by 5 minutes at 72°C. PCR products were separated on 6% denaturing polyacrylamide gels 28, 31 and then transferred to Hybond Nϩ nylon membranes. The membrane was probed with a digoxigenin-labeled (CA) 12 probe. Chemiluminescent detection with Lumigen-PPD,CSPD was performed according to the manufacturer (Boehringer Mannheim) using an antidigoxigenin antibody labeled with alkaline phosphatase. The allele sizes were scored relative to each other.
Linkage Analyses
Linkage analyses between the microsatellite polymorphic markers and Anderson's disease were performed by computer using the Linkage program package version 5.2. [35] [36] [37] An autosomal recessive mode of transmission was assumed (see Discussion). Significant evidence of linkage to the disease requires a LOD score of 3 or more (1000 to 1 odds). Exclusion of a locus is generally accepted for negative LOD scores of 2 or more. 36, 37 Further, the negative test is considered significant for values of the recombination fraction, , for which the LOD score has negative values of 2 or more, and the disease gene is excluded from this region of the genome. 38, 39 
Results
Intestinal Ultrastructure
Intestinal biopsy sections from fasted patients with Anderson's disease are heterogeneous in appearance. First, for a given patient, villi in different biopsy sections are affected to a variable extent, although all sections contain at least 1 abnormal villus (abnormal meaning containing heavily lipid laden enterocytes). Second, the percent of lipid-laden villi varies among the patients. Thus, although 100% of the villi are lipid-laden in the case of Y.Z., only 50% are lipid-laden in the cases of M.K. and O.A., and the other patients have values between these 2 extremes (Table 2 ). When Ͻ100% of the villi are lipid-laden, the remaining villi appear completely normal. Third, the region of the villus that is lipid-laden also varies among the patients. They may be affected characteristically on both sides (Sa.B., So.B., M.K., A.B., A.C., and Y.Z.) or only on 1 side (M.B.) or on 1 side in some sections and on both sides in others (O.A.) ( Table 2 ). In all the biopsy sections from all the patients, the cells in approximately the inferior one-third of the villus show no accumulation of lipids. Finally, even in the regions of the villi that contain lipid-laden enterocytes, there are always a few (a minority) morphologically normal appearing cells.
Biopsy sections from both normal fasted and fed subjects and Anderson's disease subjects were examined extensively by electron microscopy. Most enterocytes from normal fasted subjects have no intracellular and intercellular lipoprotein particles and exhibit a flat, nondistended Golgi apparatus ( Figure  2A ). In contrast, enterocytes from a normal fed subject show intracellular (white arrows in Figure 2B ) and intercellular VLDL and chylomicron-sized particles (black arrows in Figure 2B ). The intracellular lipoproteins are situated in membrane-bound vesicles and are seen budding from or located close to the Golgi apparatus. The lipoproteins are very heterogeneous in size, with diameters up to approximately 600 nm and a mean diameter of 209 nm ( Table 2 ). The extracellular lipoprotein particles are also very heterogeneous with a size distribution (mean diameter of 226 nm) roughly similar to that of the intracellular particles (Table 2 and Figure 3 ).
The heterogeneity in the biopsy sections of Anderson's disease subjects visible on light microscopic examination is also apparent when the biopsies are examined by electron microscopy. Extensive observation in the region of the villus tips of the biopsies (sections from different tissue blocks) of all the patients show that, in some regions (as represented by the biopsy from Sa.B., Figure 2C ), the enterocytes have an intracellular architecture similar to that found in normal fasted subjects. Intracellular and intercellular lipoprotein-like particles are not readily apparent, and the Golgi apparatus is flat and nondistended. In contrast, in other regions of the same biopsy (and this is the case for all the patients), the enterocytes contain large amounts of lipid particles that are scattered throughout the cytoplasm and alter the normal architecture of the cells. This lipid-laden morphology, which is typical of all the patients studied, is demonstrated by the biopsy from M.K. (Figure 2D ). Many of these particles are clearly situated in membrane-bound compartments (white arrows, Figure 2D ). Other larger particles appear to be lipid droplets located in the cytoplasm (labeled L, Figure 2D ).
Examination of these regions at higher magnification more clearly shows the heterogeneous nature of the lipid particles, as demonstrated by the biopsy from So.B. (Figure 2E ). There are large lipid droplets, up to 7043 nm in diameter that appear to be located within the cytoplasm (labeled L, Figure 2E ). These droplets are not in a membrane-bound compartment; there is neither a translucent space nor a cell membrane surrounding the droplets. The density of these particles (expressed as the number of particles per square micron) is variable among the patients (from 0.09 to 0.71 particles/ 2 ) and is significantly larger than the very limited number of intracytoplasmic lipid particles apparent in a normal fed subject (0.03 particles/ 2 ) ( Table 2 ). The mean diameters of the lipid particles vary greatly from 368 to 2127 nm in the Anderson's disease subjects and are smaller (except for Sa.B.) than the mean diameter of the intracytoplasmic lipid particles in normal fed subjects (2271 nm) ( Table 2) . No lipid-like particles were observed in the case of O.A. In addition to these large lipid droplets, there are smaller chylomicron and VLDL-sized particles. These particles are surrounded by a translucent space within a membrane-bound compartment (white arrows, Figure 2E ). Frequently, there are 1 or a few particles (Ͻten) in these compartments, which are reminiscent of dilated, vesiculated channels of the smooth endoplasmic reticulum but could also be transverse sections of Golgi apparatus. In addition, there are large membrane-bound compartments that contain many (50 or more) particles that are very heterogeneous in size. When clearly identifiable, the Golgi apparatus (stars in Figure 2E ) is empty, although frequently distended, with membrane-bound compartment containing particles in close juxtaposition. These membrane-bound lipid particles resemble lipoprotein particles seen in a normal fed subject; ( Figure 2B ) however, their size distribution is frequently skewed toward larger sizes (Figure 3 ). The mean diameter for all the Anderson's disease subjects is 305 nm, significantly larger as compared with the mean diameter of 209 nm in a normal fed subject (Table 2) . Considered individually, the mean particle diameters of all but 2 of the Anderson's disease subjects are significantly larger than those of the normal fed subject ( Table 2 ). The mean particle diameter of A.C. was not significantly different from that of the normal fed subject, whereas that of A.B. was significantly smaller (Table 2 ). Even among the Anderson's disease subjects, the mean lipoprotein-like particle size varies significantly. Further, in Anderson's disease, the average density of the membrane-bound lipoprotein-like particles, 2.34 particles/ 2 , greatly exceeds that found in the enterocytes of a normal subject, 0.66 particles/ 2 , after a meal (Table 2) . Also, when considered individually, the density of membrane-bound lipoprotein-like particles in Anderson's disease subjects (except for Sa.B. and O.A.) is significantly larger than that of the normal fed subject ( Table 2) .
The extracellular spaces in the biopsies of the patients are generally devoid of lipoprotein particles. Sometimes, however, small amounts of intercellular lipoprotein-like particles are observed (as shown for A.C., black arrows, Figure 2F ), which have a range of diameters from 50 to 150 nm with a mean diameter of 63Ϯ19 nm, not significantly different from normal fasted subjects in which the mean diameter of intercellular lipoprotein particles is 83Ϯ45 nm. Thus the ultrastructural results show that the enterocytes of Anderson's disease patients have large amounts of lipoprotein-like particles that are larger than lipoprotein-like particles in normal fed subjects and that they secrete very limited amounts of particles, which have diameters resembling small chylomicrons or VLDL.
Biosynthesis of Apolipoproteins and MTP in Intestinal Organ Culture
Immunoprecipitation with polyclonal antibodies to apo B of the total homogenate of the organ culture of intestinal biopsies from Anderson's disease patients (Sa.B., So.B., M.K., O.A., A.C.) shows the synthesis of an apo B48 identical in size to that of normal control subjects. The results for one of the patients (A.C.) are shown in Figure 4A . Densitometric scanning reveals that there is 3-to 5-fold more apo B48 present in the biopsies of the patients as compared with those of normal subjects when corrected for the amount of TCA precipitable incorporated radioactivity. Some intracellular degradation of the apo B48 may occur as evidenced by the lower molecular weight bands in the patient's biopsy as compared with the normal biopsy. Analysis of the culture media shows that all of the patients secrete a small amount apo B48 having an apparent molecular weight identical to that of the apo B48 secreted by normal subjects (as illustrated by the results with A.C. in Figure 4A ). Secretion of apo B48 from the biopsies of both affected and normal subjects began with periods of pulse or chase longer than 30 minutes. Preparative ultracentrifugation reveals that the apo B48 secreted (after a 2-hour pulse followed by a 1-hour chase) by 
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patients Sa.B., So.B., O.A., M.K., and normal subjects floats like chylomicrons at a density of Ͻ1.006 g/mL (as shown for So.B. in Figure 5A ). No apo B100 was detected in the biopsy or culture medium. As shown by the results obtained from A.C. (Figure 4B ), immunoprecipitation of biopsy homogenates from 5 patients (M.K., So.B, Sa.B., O.A., and A.C. [4 families]) with a polyclonal antibody to apo AIV showed that the patients synthesized and secreted apo AIV having a molecular weight identical to that found in normal subjects. Two proteins were found in the biopsies of both patients and normal subjects. The larger of the 2 proteins corresponded to the 1 secreted into the medium and had an electrophoretic mobility identical to pure plasma apo AIV. As quantified by immunoprecipitation and densitometric scanning, there were increased amounts of the proteins in the biopsies of Sa.B. (3.9-fold), So.B. (8.8-fold), and A.C. (1.7-fold) , as compared with the biopsy of the normal subject when corrected for the amounts of trichloroacetic acid precipitable protein incorporated radioactivity. Although there appears to be an increased amount Table 2 .
of the lower molecular weight protein relative to higher molecular protein in the biopsy of A.C. compared with the normal biopsy ( Figure 4B ), examination of several normal biopsies showed that the lower molecular weight protein may predominate in normal persons as well.
To determine whether the 2 intracellular protein forms were glycosylated differently, immunoprecipitated apo AIV was treated with endo-␤-N-acetyl glucosaminidase H or endoglycosidase F/PNGase F to remove high mannose and complex carbohydrates, respectively. No effect was observed for either endoglycosidase for biopsies from Sa.B. and So.B., suggesting that differences in N-glycosylation were not the origin for the 2 bands (results not shown). The origin of the lower molecular weight protein is unknown at present (proteolysis, alternative splicing).
Analysis of the culture medium by ultracentrifugation and gel electrophoresis was performed for Sa.B., So.B., and M.K. and showed that apo AIV was present with apo B48 in a chylomicron-like fraction that floated at a density Ͻ1.006 g/mL, as shown for M.K. in Figure 5B . Further, when this chylomicron-like fraction was immunoprecipitated with antibodies to apo B, both apo B48 and apo AIV could be detected as shown in the case of M.K. in Figure 5C . The protein immediately below apo AIV corresponds to that observed in biopsies ( Figure 4B ) and sometimes may appear in the medium. The other proteins are unidentified at present. These results indicate, in agreement with the ultrastructural results, that a small amount of chylomicron-like particles can be secreted by the enterocytes of Anderson's disease patients.
Because MTP has been shown to play an integral role in lipoprotein assembly, we examined biopsy homogenates for MTP protein on western blots and for MTP activity. The heavy (97 kDa) subunit was readily detected in the 3 patients, Sa.B., So.B., and O.A., from pedigrees 100 and 300 (results not shown). The in vitro assay results revealed that the MTP activities in the biopsy homogenates from these same patients were within the 99% confidence intervals established by the in vitro assays of 5 normal subjects ( Figure 6 ). These data indicate that a defect in MTP was highly unlikely as the molecular basis of the disease.
Exclusion of the Apolipoprotein and Lipid Transfer Protein Genes
We next used highly polymorphic microsatellite markers to perform linkage studies between several candidate genes and Anderson's disease in 5 cases (So.B., Sa.B., M.K., O.A., and A.B.) in 4 families, pedigrees 100, 200, 300, and 400 ( Figure 1) .
Because there are essentially no apo B48 -containing lipoproteins, the levels of plasma LDLs are reduced in the plasma of patients with Anderson's disease, and given the small number of patients with the disease, it is important to evaluate linkage to the apo B gene in all cases to assess the role of this protein and to determine possible heterogeneity in the cases. The apo B gene was studied using a tetranucleotide repeat located within the gene and with 2 highly polymorphic markers, D2S305 and D2S220, immediately surrounding the location of the gene on chromosome 2 (Table 3) . No evidence . Biopsies were labeled for 30 minutes followed by a chase for 1 hour. In the patient's biopsy, there were increased amounts of an apo B48 comparable in size to that in a normal subject's biopsy (A, lanes labeled B). This normal-sized apo B was also found in the medium of the patient's biopsy (A, lane marked M). When an antibody to apo AIV was used (B), 2 protein bands were found in the patient's biopsy having the same size as those in normal subjects (B, lanes marked B). An apo AIV with a size identical to that of apo AIV secreted by the normal subject's biopsy and that was identical to purified plasma apo AIV was found in the culture medium of the patient's biopsy (B, lanes marked M). Molecular mass markers include the apo B100 thrombolytic peptide, T3 (238 000). Biopsies were labeled for 30 minutes followed by a chase for 1 hour (A) and labeled for 2 hours followed by a chase of 1 hour (B and C). Biopsies were then homogenized and centrifuged as described in the Methods section to isolate a chylomicron-like fraction of density Ͻ1.006 g/mL. A, Analysis by SDS-4% PAGE after immunoprecipitation with an antibody to apo B showed the presence of a normal-sized apo B48 in a chylomicron-like fraction in both the biopsy (labeled B) and the medium (labeled M) of the patient's (So. B.) biopsy. B, Analysis by SDS (5% to 15%)-gradient PAGE of the total chylomicron fraction from the medium (labeled M) of the patient, M. K. (labeled AD) and a normal subject (labeled N) showed the presence of a normal-sized apo B48 and a normal sized apo AIV. C, Analysis by SDS (5% to 15%)-gradient PAGE of the total chylomicron fraction from the medium (labeled M) of the patient M. K. (labeled AD) and a normal subject (labeled N) after immunoprecipitation with an antibody to apo B showed the presence of a normal-sized apo B48 and a normal sized apo AIV. The arrows indicate the locations of human plasma apo B48 and apo AIV. The protein located below apo AIV corresponds to that observed intracellularly in Figure 4B . The other proteins are unidentified at present.
for linkage was found with the tetranucleotide repeat and the negative LOD scores of the 2 other markers clearly excluded any association for a distance of at least 5 cM on either side of the reported location of the gene. These results, combined with the intestinal organ culture results, clearly rule out the apo B gene as the origin of the disease in these families.
Apo AIV and apo AI are major intestinal apoproteins and are present in chylomicrons. There are increased amounts of these proteins in the enterocytes of patients with Anderson's disease 12 and chylomicron retention disease, 14 and the plasma levels of these apolipoproteins as well as those of HDL are reduced. We therefore evaluated the relationship of these major apolipoprotein genes to the disease. No highly polymorphic markers have been reported in the apo AIV or apo AI genes on chromosome 11. However, a polymorphic marker, apo CIII-IVS3, does exist within the apo CIII gene. We therefore investigated this marker as well as a series of polymorphic markers surrounding the apo AIV, apo AI, and apo CIII gene cluster ( Table 4 ). The apo CIII gene is clearly excluded. A region of approximately 15 cM in length around the location of the apo AI-CIII-AIV gene cluster is also excluded as being linked to the disease on the basis of the LOD scores of the various recombination fractions (Table 4) . These results, along with the organ culture results, effectively exclude mutations in the apo AIV, apo AI, and apo CIII gene cluster as being the cause of the disease.
Marked immunoenzymatic labeling of the C apoproteins in enterocytes and decreased plasma levels of these proteins have been noted in Anderson's disease. 12 These proteins are also chylomicron constituents; therefore, we evaluated the relationship to the disease of the other C apoproteins along with apo E. Within the apo CII gene on chromosome 19 there is a polymorphic dinucleotide repeat. We studied this marker as well as 3 other polymorphic markers spanning a region of 18 cM containing the apo CI, apo CII, and apo E genes (Table  5 ). Linkage analysis shows no evidence of segregation between Anderson's disease and this region of chromosome 19. The apo CII gene is clearly excluded by the negative LOD scores found for the marker within the gene. A region of 24 cM around the apo CII gene, which includes the apo CI and apo E genes, is also excluded.
Because a mutation in one of the major apolipoprotein genes did not appear to be the cause of Anderson's disease, we also performed linkage studies on 3 intracellular lipid transport proteins that are potential candidates for the origin of the disease. MTP plays a major role in triglyceride-rich cen *The estimated distance from the telomere is indicated in column 3. The position of the candidate genes are indicated relative to that of the markers. Two-point linkage analysis was performed as indicated in the Methods designating Anderson's disease as an autosomal recessive disease. A LOD score of 3.0 represents odds of 1000Ϻ1 that the observation is the result of linkage at the specified recombination frequency as opposed to independent segregation. A LOD score of Ϫ2 indicates the absence of linkage. Further, the disease gene is excluded from the genome for distances, , for which the LOD score has negative values Ͼ2.
lipoprotein assembly, and mutations in the heavy subunit are known to cause abetalipoproteinemia. 2 Although we have found apparently normal MTP activity in 3 patients, a genetic test would provide definitive evidence for the lack of linkage to the disease.
The patterns of inheritance in pedigrees 100, 200, and 300 for the polymorphic marker MTPIVS10 located within the MTP gene are shown in Figure 7 . In each pedigree, the presence of different genotypes in affected subjects (pedigree 100) or of an identical genotype in affected and unaffected subjects (pedigrees 200 and 300) effectively rules out the MTP gene locus as the site for the mutation causing the disease. We have found that the MTP gene is closely linked to the marker D4S406 (Dannoura et al, unpublished results, 1998). Analysis of the LOD scores as a function of the recombination fractions in the 4 families between the disease and the locus D4S406 (Table 6 ) also excludes this locus in agreement with the above results. These results, combined with the results obtained with the other highly polymorphic markers on chromosome 4, exclude an extended area of approximately 30 cM surrounding the MTP gene on chromosome 4 (Table 6 ) as a cause of the disease.
Fatty acid binding proteins perform important intracellular lipid transport functions that may be essential for triglyceride-rich lipoprotein production. Chromosome 4 also contains the gene for intestinal fatty acid binding protein, FABP2.
Highly polymorphic markers spanning a region of more than 15 cM on either side of the reported location for the FABP2 gene were analyzed. The LOD scores and recombination fractions (Table 6 ) effectively exclude the FABP2 gene as well as any other genes located in an area of 30 cM surrounding the gene.
No highly polymorphic markers have been described in the FABP1 gene, which is located on chromosome 2. We therefore examined several markers spanning a region of 12 cM around the reported location of the gene. On the basis of the negative LOD scores and the recombination fractions for all the polymorphic markers studied (Table 3) , a region of 20 cM surrounding the location of the FABP1 gene is excluded as being linked to the disease.
Discussion
The study of inherited disorders of apo B-containing lipoproteins have provided important insights into the roles of apolipoprotein (apo B in the case of hypobetalipoproteinemia) and non-apolipoprotein (MTP in the case of abetalipoproteinemia) factors in normal human chylomicron and VLDL assembly and secretion. In the present report, we have performed biochemical, cell biological, and ultrastructural analyses to assess the role of apolipoprotein and nonapolipoprotein factors in the pathogenesis of Anderson's disease. We have, in addition, specifically tested the hypothesis that 1 of the major apolipoprotein genes or that 1 of 3 
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important intracellular lipid transport genes is linked to Anderson's disease. We first investigated the intestinal biopsies of 8 affected subjects from 7 families. Our patients had been maintained on a low-fat, lipid-soluble vitamin-supplemented diet for at least 6 months before their biopsy, which was performed after 12 to 15 hours fasting. Even after this treatment and abatement of the gastrointestinal symptoms, biopsies remained lipidladen with lipoprotein-and lipid-like particle densities exceeding those found in the normal fed subject. Three major conclusions derive from the ultrastructural analysis. The first is that there are chylomicron-and VLDL-sized particles (approximately 300 nm in diameter, range 169 to 580 nm) in membrane-bound compartments as has been described for several cases of chylomicron retention disease. 14,20 Second, although rare, smaller particles (63 nm mean diameter) can be found in the intercellular spaces of affected subjects suggesting that secretion may occur. Third, there are other, larger intracellular lipid particles (from 368 to 2127 nm mean diameter) that do not appear to be located in a membranebound compartment. All the patients have these 2 types of particles.
The identity of the membrane-bound compartment that contains the lipoprotein-sized particles is not entirely clear, nor is the composition of the particles. Because the cells are so heavily lipid-laden, the location of the vesicles is not useful for the identification of the membrane-bound compartment. There is a remarkable resemblance between some of the particle-bearing membrane bound compartments observed in the present study and the images of putative second-step triglyceride-rich particles found in the endoplasmic reticulum of transgenic apo B deficient mice (see Figures 9 to 11 in reference 40) in which assembly does not occur due to the absence of apo B. The particles not situated in Figure 7 . Exclusion of the MTP locus. The genotypes for a polymorphic CA n -type microsatellite marker, MTPIVS10, in intron 10 of the MTP gene on chromosome 4 in pedigrees 100, 200, and 300 were determined as described in Methods. Affected subjects in the same family have different genotypes or they have the same genotype as their apparently normal siblings thus excluding the locus. Table 3 . membrane vesicles, also described in other cases of Anderson's disease and chylomicron retention disease, 14, 16, 18 are also reminiscent of the lipid droplets found in the cytoplasm in transgenic mice deficient in apo B synthesis (see Figure 10 in reference 40 and Figure 4 in reference 41) or observed in cases of abetalipoproteinemia, 14, 22 where assembly does not occur due to the absence of MTP. Based on the ultrastructural observations in transgenic mice deficient in apo B synthesis, 40, 41 the lipid droplets in the cytoplasm of our patients could derive from the breakdown of membrane-bound compartments that contain unassembled lipid particles (putative second step triglyceride-rich particles). However, both the transgenic apo B deficient mouse model and patients with abetalipoproteinemia differ from patients with Anderson's disease. In Anderson's disease, as well as chylomicron retention disease, immunochemical analysis of enterocytes has shown the presence of increased amounts of apo B, 12, 14 and we have shown that MTP is present and active in Anderson's disease (reference 23 and this work). Further, the ultrastructural aspects of enterocytes in cases of abetalipoproteinemia, in which apo B is present intracellularly but MTP is inactive, and Anderson's disease are very different. Large nonmembrane-bound lipid droplets predominate in abetalipoproteinemia, whereas smaller membrane-bound particles predominate in Anderson's disease and chylomicron retention disease. The presence of apo B48 (this study and reference 15) and apo AIV (this study) in chylomicron fractions isolated from biopsies of patients with Anderson's disease or chylomicron retention disease suggest that assembly of some kind of lipid-rich lipoprotein particle can take place. Further, as opposed to 3 cases of abetalipoproteinemia with established mutations in MTP that we have studied (unpublished results), biopsies from patients with Anderson's disease secrete some apo B48 along with apo AIV into the culture medium in a chylomicron-density range. If transport to the Golgi apparatus is defective, assembled or partially assembled particles, as well as putative second step triglyceride-rich lipid particles, could accumulate in an endoplasmic reticulum compartment. Alternatively, transport of postGolgi secretory vesicles could be defective.
Some studies of biopsies obtained from fasted patients have suggested that the lipoprotein-sized particles are present in both the endoplasmic reticulum and the Golgi apparatus. 7, 8, 14, 20 Other studies, however, suggest that the Golgi is normal but empty 16, 18 and that the particles are located in the endoplasmic reticulum only. 18 After feeding, increased amounts of particles have been reported to be in the smooth endoplasmic reticulum, 18, 20 whereas the Golgi became narrow and empty. 20 Strich et al 18 have suggested that the particles in Anderson's disease are, in fact, in the endoplasmic reticulum and that they do not reach the Golgi, thus explaining the decreased glycosylation (decreased incorporation of mannose) that has been observed in chylomicron retention disease. 15 Decreased incorporation of mannose has also been reported in vitamin A deficiency. 42 Anderson's and chylomicron retention disease patients are frequently deficient in vitamin A; however, the role of vitamin A and glycosylation in Anderson's disease has not been studied.
In our cases, the Golgi apparatus is often distended, but it is generally empty. However, particles in membrane-bound compartments are in close proximity and sometimes appear to be part of the Golgi stack or to be budding off the lateral aspect of the Golgi. It is noteworthy that, in our patients, the particles in the membrane-bound compartments are larger and more numerous than the membrane-bound particles in normal fed subjects. Double immunogold labeling of apolipoproteins and cell compartment markers may allow the identification of the cell compartment (reticulum, Golgi, post-Golgi) to which the particle laden membrane-bound vesicles belong. 43 A biochemical approach to determine whether the lipoprotein-like particles do indeed reach the Golgi apparatus in Anderson's disease patients would be to determine whether the apo B48 contains complex carbohydrates, the acquisition of which occurs in the Golgi apparatus.
In preliminary results, we have found that treatment with endoglycosidase H and PNGase F of metabolically labeled apo B48 from Anderson's disease patients does indeed show that the protein has acquired complex carbohydrates. This acquisition of complex carbohydrates does not occur in brefeldin-treated biopsies nor in abetalipoproteinemic patients in which transport of apo B-containing lipoproteins to the Golgi is blocked or does not occur (unpublished results). Quantitation of the extent of complex glycosylation could help determine what proportion of apo B48 does indeed attain the Golgi apparatus.
For the linkage analysis, we were able to study 4 families. Highly polymorphic microsatellite markers, most frequently the (CA) n type, were used to establish the haplotypes in all the family members. These tandem repeats of a simple short nucleotidic sequence offer several advantages. They are abundant and uniformly distributed along the human genome. 31, 33, 34 They exhibit, in general, a greater degree of polymorphism compared with the other genetic markers such as restriction fragment length polymorphisms. Finally, a large number of these markers have been situated with respect to one another and with respect to many genes with considerable accuracy within each chromosome. 33, 34 The choice of the genetic model and an appreciation of the genetic homogeneity of the cases are important considerations. The diagnostic criteria for Anderson's disease or chylomicron retention disease are quite specific and encompass biochemical, endoscopical, histological, ultrastructural, and clinical aspects as described in the Methods section. All the patients reported in the literature and all the patients studied in this report exhibited these characteristics at the time of diagnosis. The parents of all the patients studied here were asymptomatic.
Anderson's disease and chylomicron retention disease are clearly distinguishable from abetalipoproteinemia and homozygous hypobetalipoproteinemia (null alleles), particularly by the presence of apo B100 -containing lipoproteins but also by the absence of acanthocytosis, retinitis pigmentosa, and severe neurological symptoms. Anderson's disease is also clearly distinguishable from heterozygous familial hypobetalipoproteinemia and homozygous familial hypobetalipoproteinemia (with truncated apo B) by the presence of diarrhea, malabsorption, and steatorrhea. Finally, the mode of inheritance (recessive versus dominant for familial hypobetalipoproteinemia) and the clear involvement of the apo B gene in familial hypobetalipoproteinemia further differentiate the disorders.
Thirty-five cases of Anderson's disease or chylomicron retention disease in 26 families have been reported in the literature. 4 -21 Of these cases, 16, from ten different families, 5,7,9,12,13,16 -18 are of North African origin (Algeria, Morocco, Tunisia). Ten cases are from 9 Canadian families. 6, 11, 14, 15 The 9 remaining cases are from 6 different countries. 4,8,10,19 -21 Of the 26 families, consanguinity is found in 9, no consanguinity is present in 12, and information regarding consanguinity is not available in 5.
The autosomal recessive model used here for the genetic analysis of Anderson's (chylomicron retention) disease is based, therefore, on the following: there are 7 families with 2 or more cases, the parents are phenotypically normal (clinically asymptomatic with normal lipid values), 14 girls and 21 boys are affected. Of the 4 families used for the linkage analysis in this study, 3 have consanguinity. All 7 families that we studied here are of North African origin.
In addition to the absence of apo B48 -containing lipoproteins, major biochemical hallmarks of the patients described with Anderson's disease or chylomicron retention disease include the low levels of plasma LDL and HDLs and decreased plasma levels of apo AI. The role of the various apolipoproteins in chylomicron assembly and secretion is still poorly understood in spite of considerable progress. Other than their participation as structural elements, apolipoproteins have not been attributed other functions important for chylomicron assembly and secretion. However, given the exceptional diversity in the physiological functions of some apolipoproteins, it would not be surprising that they play roles, either directly or indirectly, in the assembly and secretion processes.
Given the complete absence of apo B48 -containing lipoproteins in the disease, the apo B gene has long been considered a candidate. Further, given the rarity of the disease and possible heterogeneity, it is important to evaluate all cases as to the involvement of the apo B gene. No evidence of linkage was found between the disease and the microsatellite repeat located in the apo B gene nor in the region of chromosome 2 surrounding the gene. Further, the intestinal organ culture shows the synthesis and secretion of a normal sized apo B48. These results effectively rule out the apo B gene locus as the origin of the disease in these 4 families. Pessah et al 17 Apo B48 is not, however, the only apolipoprotein expressed by the intestine. Analysis of mRNA synthesis in the human intestine has shown the presence of mRNA for apolipoproteins AI, AIV, E, CII, and CIII. 44 -47 In addition to apo B48, apo AI, apo AIV, apo CII, and apo CIII have been detected in human intestine by immunochemical techniques. 12,14,43,48 -51 Apo AI and apo AIV are major intestinal apoproteins and have been detected in increased amounts in enterocytes of patients with Anderson's disease 12 or chylomicron retention disease, 14 as have the C apoproteins. 12 These proteins have been reported to be components of human chylomicrons. 52 Further, decreased plasma levels of these proteins have been reported in patients. 12, 14 It has been suggested that apo E has a function in the hepatic VLDL assembly and secretion cascade. 53 The role, if any, of apoproteins other than apo B, in human intestinal chylomicron and VLDL assembly is unknown. In fact, the majority of current knowledge concerning lipoprotein assembly has been derived from transformed hepatic cell lines. Intestinal chylomicron assembly and secretion may well differ, in certain respects, from hepatic triglyceride-rich lipoprotein assembly and secretion. The existence of Anderson's or chylomicron retention disease is, perhaps, one of the best indications of this difference. Thus, to clearly establish the relationship of these apoproteins to Anderson's disease, we evaluated their genes as well as large regions of the chromosomes surrounding the genes for linkage to the disease.
The results reported here exclude the genes of all of these proteins (apo AI, apo AIV, apo B, apo E, apo CI, apo CII, and apo CIII) as being linked to Anderson's disease. In addition, the LOD scores as a function of the recombination fractions effectively exclude any genes located in defined regions around these genes: approximately 18 cM around the apo B gene on chromosome 2; approximately 15 cM around the apo AI, apo CIII, apo AIV gene cluster on chromosome 11; and approximately 24 cM around the apo CII, apo E, and apo CI genes on chromosome 19.
Given that the major apolipoproteins produced in the intestine are effectively excluded as causes for Anderson's disease, we investigated intracellular lipid transport proteins that could play indispensable roles in lipoprotein assembly and secretion. MTP protein has recently been shown to be implicated in lipoprotein assembly, and mutations in the large subunit of this complex have been found to be the molecular basis for several cases of abetalipoproteinemia. 2 In previous work, we showed that MTP protein and activity were present in 1 case (M.K.) of Anderson's disease 23 from pedigree 200. Given the rareness of the disease and the important role of MTP in lipoprotein assembly, it is important to clearly establish the lack of association of the disease with the MTP complex in more than 1 subject. In this study we have tested 3 additional cases from 2 different families, pedigrees 100 and 300. MTP large subunit proteins were clearly present in the intestinal biopsies of all 3 subjects as well as MTP activity. It was necessary to demonstrate that the MTP protein was active because we have detected the presence of a normal-sized inactive MTP protein with a false sense mutation in a case of abetalipoproteinemia. 54 The linkage analysis definitively ruled out the MTP gene as well as any other genes located in a 30 cM region around the gene.
Interestingly, the gene for intestinal fatty acid binding protein is located in this region. This protein, which is important for facilitating intracellular uptake and trafficking of fatty acids to the site of triacylglycerol biosynthesis, is also a potential candidate for the disease. Although 3 studies 6, 8, 15 have suggested that intracellular triglycerides are formed and constitute the majority of the intracellular lipid, it is clear that alterations in the levels of fatty acid binding protein might affect lipoprotein biosynthesis. 55 However, we find no evidence of linkage between the FABP2 gene and Anderson's disease. Another fatty acid binding protein that is also expressed in the intestine is hepatic fatty acid binding protein, FABP1. Use of polymorphic markers spanning the region where the gene is located revealed no evidence of linkage and the LOD scores effectively ruled out a 20-cM region of the chromosome surrounding the location of the gene. Taken together, these results suggest that fatty acid transport mediated by fatty acid binding proteins 1 and 2 should be normal in subjects with Anderson's disease.
In conclusion, the results of the present study clearly show that chylomicron-like particles can be observed intracellularly in membrane-bound vesicles in enterocytes in Anderson's disease as has been reported in chylomicron retention disease. 14 We have further quantitated the variability in the ultrastructural aspects and defined the characteristics of the lipid and lipoprotein-like particles in our patients as well as showing that lipoprotein-like particles are also present, although rarely, in the intercellular spaces in biopsies. Small amounts of normal-sized apoproteins B and AIV are secreted into the medium in complexes having densities similar to chylomicrons suggesting that lipoprotein assembly may occur and that a small amount of secretion may take place in agreement with the ultrastructural observations and with some reports of other patients with Anderson's disease. 4, 18 However, increased amounts of normal sized apo B48 and apo AIV are present intracellularly. Finally, defects in the genes encoding the apolipoproteins expressed in the intestine (AI, AIV, B, CI, CII, CIII, and E) are excluded as causes of Anderson's disease as are mutations in the genes encoding 3 intracellular lipid transport proteins (MTP, FABP1, and FABP2). Exclusion of these genes clearly suggest the importance of another factor for human intestinal chylomicron secretion. Future studies would profit from an assessment of the basolateral secretion of proteins other than apolipoproteins to determine whether the defect in this disease specifically affects lipoproteins or affects basolateral enterocyte secretion in general. Finally, a genome-wide genetic linkage analysis of a larger group of families with affected subjects is justifiable given current technology.
